Search research articles
Contact Us
Filters
Showing results (1-10 of 26) with videos related to
Page
of 3
Sort By:
Clinical and Experimental Gastroenterology
|
February 1, 2024
Magnetic Resonance Enterography Assessment of Transmural Healing with Vedolizumab in Moderate to Severe Crohn's Disease: Feasibility in the VERSIFY Phase 3 Clinical Trial
Jordi Rimola, Jean-Frédéric Colombel, Brian Bressler, et al.
Targeted Oncology
|
April 27, 2023
Comparison of Cerebral Blood Flow in Regions Relevant to Cognition After Enzalutamide, Darolutamide, and Placebo in Healthy Volunteers: A Randomized Crossover Trial
Steven C R Williams, Ndaba Mazibuko, Owen O'Daly, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
July 3, 2014
Robustness of automated hippocampal volumetry across magnetic resonance field strengths and repeat images
Robin Wolz, Adam J Schwarz, Peng Yu, et al.
The Journal of Thoracic and Cardiovascular Surgery
|
June 14, 2002
Midterm follow-up of penetrating ulcer and intramural hematoma of the aorta
Shawn L Tittle, Raymond J Lynch, Patricia E Cole, et al.
Radiology
|
May 23, 2017
Repeatability of MR Elastography of Liver: A Meta-Analysis
Suraj D Serai, Nancy A Obuchowski, Sudhakar K Venkatesh, et al.
Neurobiology of Aging
|
November 12, 2013
Operationalizing hippocampal volume as an enrichment biomarker for amnestic mild cognitive impairment trials: effect of algorithm, test-retest variability, and cut point on trial cost, duration, and sample size
Peng Yu, Jia Sun, Robin Wolz, et al.
Clinical Lung Cancer
|
August 25, 2011
A phase II study of eribulin mesylate (E7389) in patients with advanced, previously treated non-small-cell lung cancer
Alexander I Spira, Nicholas O Iannotti, Michael A Savin, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
March 19, 2011
Global issues in drug development for Alzheimer's disease
Rachelle S Doody, Patricia E Cole, David S Miller, et al.
Cancer Biotherapy & Radiopharmaceuticals
|
May 20, 2021
<i>In Vitro</i> and <i>In Vivo</i> Comparison of 3,2-HOPO Versus Deferoxamine-Based Chelation of Zirconium-89 to the Antimesothelin Antibody Anetumab
Jyoti Roy, Elaine M Jagoda, Falguni Basuli, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 3, 2014
The influence of biological and technical factors on quantitative analysis of amyloid PET: Points to consider and recommendations for controlling variability in longitudinal data
Mark E Schmidt, Ping Chiao, Gregory Klein, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 26) with videos related to
Sort By:
Page
of 3
Clinical and Experimental Gastroenterology
|
February 1, 2024
Magnetic Resonance Enterography Assessment of Transmural Healing with Vedolizumab in Moderate to Severe Crohn's Disease: Feasibility in the VERSIFY Phase 3 Clinical Trial
Jordi Rimola, Jean-Frédéric Colombel, Brian Bressler, et al.
Targeted Oncology
|
April 27, 2023
Comparison of Cerebral Blood Flow in Regions Relevant to Cognition After Enzalutamide, Darolutamide, and Placebo in Healthy Volunteers: A Randomized Crossover Trial
Steven C R Williams, Ndaba Mazibuko, Owen O'Daly, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
July 3, 2014
Robustness of automated hippocampal volumetry across magnetic resonance field strengths and repeat images
Robin Wolz, Adam J Schwarz, Peng Yu, et al.
The Journal of Thoracic and Cardiovascular Surgery
|
June 14, 2002
Midterm follow-up of penetrating ulcer and intramural hematoma of the aorta
Shawn L Tittle, Raymond J Lynch, Patricia E Cole, et al.
Radiology
|
May 23, 2017
Repeatability of MR Elastography of Liver: A Meta-Analysis
Suraj D Serai, Nancy A Obuchowski, Sudhakar K Venkatesh, et al.
Neurobiology of Aging
|
November 12, 2013
Operationalizing hippocampal volume as an enrichment biomarker for amnestic mild cognitive impairment trials: effect of algorithm, test-retest variability, and cut point on trial cost, duration, and sample size
Peng Yu, Jia Sun, Robin Wolz, et al.
Clinical Lung Cancer
|
August 25, 2011
A phase II study of eribulin mesylate (E7389) in patients with advanced, previously treated non-small-cell lung cancer
Alexander I Spira, Nicholas O Iannotti, Michael A Savin, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
March 19, 2011
Global issues in drug development for Alzheimer's disease
Rachelle S Doody, Patricia E Cole, David S Miller, et al.
Cancer Biotherapy & Radiopharmaceuticals
|
May 20, 2021
<i>In Vitro</i> and <i>In Vivo</i> Comparison of 3,2-HOPO Versus Deferoxamine-Based Chelation of Zirconium-89 to the Antimesothelin Antibody Anetumab
Jyoti Roy, Elaine M Jagoda, Falguni Basuli, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 3, 2014
The influence of biological and technical factors on quantitative analysis of amyloid PET: Points to consider and recommendations for controlling variability in longitudinal data
Mark E Schmidt, Ping Chiao, Gregory Klein, et al.
Page
of 3